Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

 

It Isn’t Just Joint Pain
21:50

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Adverse Events - Immunobiology of CPIs and Autoimmunity: PD-1 Pathway and Activity Is Similar to That Displayed by Cancer Patients on Anti-PD-1 Therapy

FEATURING Leonard Calabrese
  • 37 views
  • March 24, 2020
16:28

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Immunologic Basis of Adverse Events: Does Immunosuppression Used for Therapy of irAEs Compromise Anti-tumoral Immunity?

FEATURING Leonard Calabrese
  • 332 views
  • March 24, 2020
  • 1
09:52

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Cell Differentiation Therapies

FEATURING Leonard Calabrese
  • 248 views
  • March 24, 2020
  • 3
19:05

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Rheumatic Immune Related Adverse Events from CPIs: Current and New Treatments Proliferate in Community Practice

FEATURING Cassandra Calabrese
  • 15 views
  • March 24, 2020
18:50

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

62 y/o Male With Stage IV Renal Cell Carcinoma: Managing Rheumatic Immune Side Effects from CPIs

FEATURING Elizabeth Kirchner, Cassandra Calabrese, Leonard Calabrese
  • 22 views
  • March 24, 2020